NAD+-CONVERTING ENZYMES IN NEURONAL AND GLIAL CELLS: CD38 AS A NOVEL TARGET FOR NEUROPROTECTION

N. A. Malinovskaya, Olga L. Lopatina, T. E. Taranunushenko

Annals of the Russian academy of medical sciences · 2012 · 21 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

The review contains current data on molecular mechanisms which control NAD+ homeostasis in brain cells. It also deals with the role of NAD+-converting enzymes in regulation of functional activity, viability and intercellular communication of neuronal and glial cells. Special attention is paid to involvement of CD38 into regulation of NAD+ levels in brain cells in normal and pathological conditions.